Stock Events

Seres Therapeutics (MCRB) Q2 2024 Earnings

MCRB -3.26%
8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.5
-0.15
0.2
0.55

Details

Expected EPS
-0.341667
Actual EPS
-0.27
Surprise EPS
0.07
Surprise Percent
+20.98%

Description

Seres Therapeutics (MCRB) has reported earnings of -0.27 per share for Q2 2024.

0 Comments

Share your thoughts